Nan Yang, PhD
About Me
Dr. Yang is an Assistant Professor of Neuroscience, a member at Black Family Stem Cell Institute, Friedman Brain Insititute and Ronald M. Loeb Center for Alzheimer's Disease. Her laboratory is focused on the understanding of the molecular programs that control the development of distinct cell types in the brain and the developing of approaches using human stem cells combined of gene editing to advance our knowledge of the fundamental processes underlying human neural development in normal and pathological conditions. They use in vitro 2D and 3D models to decipher the phenotypic consequences of disease-causing mutations in human neurons and other neural lineages as well as the development of novel therapeutic gene targeting and cell transplantation-based strategies for numerous neuropsychiatric disorders.
Learn more about the Yang Laboratory.
Language
English
Position
ASSOCIATE PROFESSOR | Neuroscience
Research Topics
Alzheimer's Disease, Autism, Cell Biology, Cellular Differentiation, Chromatin, Developmental Neurobiology, Epigenetics, Epigenomics, Gene Regulation, Gene editing, Induced pluripotent stem cells, Molecular Biology, Myelination, Neuroscience, Parkinson's Disease, Psychiatry, Regeneration, Reprogramming, Schizophrenia, Stem Cells, Synapses, Synaptogenesis
Multi-Disciplinary Training Areas
Development Regeneration and Stem Cells [DRS], Neuroscience [NEU]
Education
Exchange student, University of California, San Francisco
PhD, Fundan University
Postdoctoral, Stanford University
Awards
2014
NARSAD Young Investigator
Research
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Yang did not report having any of the following types of financial relationships with industry and other outside entities during 2025 and/or 2026: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.